By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – German firms GATC Biotech and LifeCodexx announced today that they have begun a clinical validation study of a non-invasive, prenatal diagnostic test for Trisomy 21 based on next-generation sequencing technology.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: new chromatin imaging approach, and more.
University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.
Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.
Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.